Major trial outcomes at ASH 2021: PANTHER, AGILE, and LACEWING
1 year ago
[{"url":"https://i.ytimg.com/vi/b3Vai9no0OY/hq720.jpg?sqp=-oaymwEcCOgCEMoBSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLBSXSSS5eZOt2puxy9E7JL8TcC08A","width":360,"height":202},{"url":"https://i.ytimg.com/vi/b3Vai9no0OY/hq720.jpg?sqp=-oaymwEcCNAFEJQDSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLD-6gOdv0V2PXVZC6Yb3egNZvz8Gg","width":720,"height":404}]
{"url":"https://i.ytimg.com/an_webp/b3Vai9no0OY/mqdefault_6s.webp?du=3000&sqp=CObcsKkG&rs=AOn4CLCR2SpZrVPGXEr8ocPNk_q9Lvo9uw","width":320,"height":180}
[{"text":"Thomas Cluzeau, MD, PhD, Central University Hospital of Nice, Nice, France, talks on major trial outcomes in the acute myeloid\u00a0..."}]
{"name":"VJHemOnc \u2013 Video Journal of Hematological Oncology","id":"UCsQXL4_zTA-FoG9RA1tEGiw","thumbnails":[{"url":"https://yt3.ggpht.com/tLfkaYbACnFuAto-jU_XMyorvysy280aW3Kj1oDAKOH7nd58XYlz5rEL24x9ScNjruMr2YYw9w=s68-c-k-c0x00ffffff-no-rj","width":68,"height":68}],"link":"https://www.youtube.com/channel/UCsQXL4_zTA-FoG9RA1tEGiw"}
{"title":"Major trial outcomes at ASH 2021: PANTHER, AGILE, and LACEWING by VJHemOnc \u2013 Video Journal of Hematological Oncology 130 views 1 year ago 1 minute, 59 seconds","duration":"1 minute, 59 seconds"}